Anixa Biosciences announces issuance of Canadian patent for ovarian cancer vaccine technology
ANIX•Anixa Biosciences announced the issuance of a Canadian patent for its ovarian cancer vaccine technology.
ANIX•Anixa Biosciences announced the issuance of a Canadian patent for its ovarian cancer vaccine technology.
Anixa Biosciences announced the issuance of a Canadian patent for its ovarian cancer vaccine technology.